NeuroPace (NPCE) Shareholder's Equity (2020 - 2026)

NeuroPace (NPCE) Shareholder's Equity (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shareholder's Equity (Qtr)
1	Abbott Laboratories	157.80 Bn	151.14 Bn	6.27 Bn	52.06 Bn
2	Stryker	115.54 Bn	112.66 Bn	3.81 Bn	22.98 Bn
3	Medtronic	103.44 Bn	95.27 Bn	5.76 Bn	49.20 Bn
4	Boston Scientific	72.38 Bn	71.17 Bn	3.61 Bn	26.10 Bn
5	Edwards Lifesciences	49.76 Bn	46.09 Bn	1.29 Bn	10.33 Bn
6	Dexcom	29.53 Bn	28.42 Bn	750.30 Mn	2.96 Bn
7	GE HealthCare Technologies	29.51 Bn	27.44 Bn	1.98 Bn	10.67 Bn
8	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	13.34 Bn
9	Steris	20.69 Bn	20.27 Bn	697.10 Mn	7.20 Bn
10	NeuroPace	526.99 Mn	473.01 Mn	18.05 Mn	14.45 Mn

Download Data